MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion’s Stalevo® tablets.
MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Orion’s Stalevo® tablets.
